When is $CTIX hosting there shareholders meeting?
Post# of 72440
That's some exciting news today from the company.
"Ronald Trust, PhD, MBA, has been retained as a consultant to the Company to oversee regulatory affairs pertaining to the planned Brilacidin Phase 3 program for Acute Bacterial Skin and Skin Structure Infections"
http://www.otcmarkets.com/stock/CTIX/news